Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Pei, Hanjun
OPC, NCT02698852: A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES)	Active, not recruiting	N/A	1000	RoW	BuMA Supreme	Sino Medical Sciences Technology Inc.	Coronary Artery Disease	05/19	12/25
NCT04995159: Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVasâ„¢ BRS System	Not yet recruiting	N/A	2150	RoW	Single anti-platelet therapy, SAPT strategy, Dual anti-platelet therapy, DAPT strategy	Lepu Medical Technology (Beijing) Co., Ltd.	Coronary Heart Disease	01/26	01/28